Biweekly cetuximab plus FOLFIRI regimen in advanced colorectal cancer with K-Ras wild-type patients:results of a phase Ⅱ single institution trial

ZHU Liangjun; LI Sheng; FENG Jifeng; CHEN Jia; PAN Liangxi; CHEN Hngbo; SUN Xiaofeng; ZHU Liqun

doi:10.3969/j.issn.1009-0460.2013.01.009

Home>Articles>Biweekly cetuximab plus FOLFIRI regimen in advanced colorectal cancer with K-Ras wild-type patients:results of a phase Ⅱ single institution trial

DOI: 10.3969/j.issn.1009-0460.2013.01.009

Biweekly cetuximab plus FOLFIRI regimen in advanced colorectal cancer with K-Ras wild-type patients:results of a phase Ⅱ single institution trial

ZHU Liangjun

LI Sheng

FENG Jifeng

CHEN Jia

PAN Liangxi

CHEN Hngbo

SUN Xiaofeng

ZHU Liqun

Machine-generated Keywords：

Publication Date：2013-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：6( 39-44 )

Chinese Clinical Oncology

PKUISTIC

ISSN：1009-0460

Year, Vol.(Issue)：2013,18(1)